NFE2L2 and metabolic dysfunction-associated steatotic liver disease: In this study, we used FFA-induced nonalcoholic fatty liver cells as a model and investigated whether fucoxanthin regulated AMPK, Nrf2, and TLR4 pathways in FFA-induced NAFLD.